Vitamin B12 plays a central role in this process
It is a known, though uncommon, risk associated with GLP-1 medications
According to the Summary of Product Characteristics (SmPC), these include: Nausea (very common, affecting more than 1 in 10 people) Diarrhoea (very common) Decreased appetite (very common) Vomiting (common, affecting up to 1 in 10 people) Constipation (common) Abdominal pain (common) Dyspepsia (common) Cholelithiasis (common) Headache (common) These gastrointestinal effects typically occur during the initial weeks of treatment or following dose escalation, and often diminish over time as the body adjusts to the medication
Establish a systematic rotation pattern, such as: Week 1: Right abdomen Week 2: Left abdomen Week 3: Right thigh Week 4: Left thigh Week 5: Right upper arm Week 6: Left upper arm Week 7: Return to right abdomen This approach ensures each site receives adequate recovery time between injections
Warfarin Interactions BNF NICE
Peptides are shipped as lyophilized powder because it's stable
